128 related articles for article (PubMed ID: 27869413)
41. Anti-rubella, Mumps and Measles IgG Antibodies in Medical Students of Tehran University.
Keshavarz M; Nicknam MH; Tebyanian M; Shahkarami MK; Izad M
Iran J Allergy Asthma Immunol; 2016 Jun; 15(3):244-50. PubMed ID: 27424140
[TBL] [Abstract][Full Text] [Related]
42. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
Kremer JR; Schneider F; Muller CP
Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
[TBL] [Abstract][Full Text] [Related]
43. Serological survey: immunity to vaccine preventable diseases among detainees at a Juvenile Hall facility.
Strassburg MA; Baker CJ; Minkowski W; Friedlander L
J Adolesc Health Care; 1982 Sep; 3(2):91-5. PubMed ID: 7141946
[TBL] [Abstract][Full Text] [Related]
44. Revaccination of children with acute lymphoblastic leukemia following completion of chemotherapy.
Anafy A; Gilad G; Michaan N; Elhasid R; Rosenfeld-Kaidar H; Arad-Cohen N; Cohen MS; Shachor-Meyouhas Y; Grisaru-Soen G
Pediatr Blood Cancer; 2023 Jun; 70(6):e30321. PubMed ID: 37036274
[TBL] [Abstract][Full Text] [Related]
45. Predictive value of immunization records and risk factors for immunization failure in internationally adopted children.
Verla-Tebit E; Zhu X; Holsinger E; Mandalakas AM
Arch Pediatr Adolesc Med; 2009 May; 163(5):473-9. PubMed ID: 19414695
[TBL] [Abstract][Full Text] [Related]
46. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
Pisón Garcés FJ; Galbe Sánchez-Ventura J; Arcauz Eguren P; Aguirre y Dabán C; Mengual Gil J; Larrad Mur L
Aten Primaria; 1995 Mar; 15(4):235-7. PubMed ID: 7703334
[TBL] [Abstract][Full Text] [Related]
47. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia.
Alanko S; Pelliniemi TT; Salmi TT
Cancer; 1992 Mar; 69(6):1481-6. PubMed ID: 1540885
[TBL] [Abstract][Full Text] [Related]
48. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
[TBL] [Abstract][Full Text] [Related]
49. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
Buxbaum S; Doerr HW; Allwinn R
Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730
[TBL] [Abstract][Full Text] [Related]
50. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
[TBL] [Abstract][Full Text] [Related]
51. Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study.
Domínguez A; Plans P; Costa J; Torner N; Cardenosa N; Batalla J; Plasencia A; Salleras L
Eur J Clin Microbiol Infect Dis; 2006 May; 25(5):310-7. PubMed ID: 16786377
[TBL] [Abstract][Full Text] [Related]
52. [Serological assay of measles and rubella immunity in a sample of infantile population in palermo (author's transl)].
Arista S; Ammatuna P; Leggio M; Chiarini A
Ann Sclavo; 1980; 22(1):42-8. PubMed ID: 7247483
[TBL] [Abstract][Full Text] [Related]
53. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
Theeten H; Hutse V; Hens N; Yavuz Y; Hoppenbrouwers K; Beutels P; Vranckx R; Van Damme P
Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123
[TBL] [Abstract][Full Text] [Related]
54. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2007 Sep; 45(5):637-42. PubMed ID: 17683001
[TBL] [Abstract][Full Text] [Related]
55. Diverse effects on vaccine-specific serum IgG titres and memory B cells upon methotrexate and anti-TNF-α therapy in children with rheumatic diseases: A cross-sectional study.
Ingelman-Sundberg HM; Laestadius Å; Chrapkowska C; Mördrup K; Magnusson B; Sundberg E; Nilsson A
Vaccine; 2016 Mar; 34(10):1304-11. PubMed ID: 26827664
[TBL] [Abstract][Full Text] [Related]
56. Current status of active immunization procedures.
Ferrer-Pí S; Roldán ML
Paediatrician; 1979; 8(1-2):83-92. PubMed ID: 471518
[TBL] [Abstract][Full Text] [Related]
57. Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia.
Lehrnbecher T; Schubert R; Behl M; Koenig M; Rose MA; Koehl U; Meisel R; Laws HJ
Br J Haematol; 2009 Dec; 147(5):700-5. PubMed ID: 19764991
[TBL] [Abstract][Full Text] [Related]
58. [Investigation of measles, rubella and varicella IgG antibody levels among migrant and native pupils in Changning District of Shanghai].
Pang H; Zhang ZS; Liu HL
Zhongguo Yi Miao He Mian Yi; 2009 Jun; 15(3):223-5. PubMed ID: 20084886
[TBL] [Abstract][Full Text] [Related]
59. Adolescent immunizations: missed opportunities for prevention.
Lee GM; Lorick SA; Pfoh E; Kleinman K; Fishbein D
Pediatrics; 2008 Oct; 122(4):711-7. PubMed ID: 18829792
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of hepatitis B markers and measles, mumps, and rubella antibodies among Jewish refugees from the former Soviet Union.
Hurie MB; Gennis MA; Hernandez LV; Dindzans VJ; Davis JP
JAMA; 1995 Mar 22-29; 273(12):954-6. PubMed ID: 7884955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
